In silico search for multi-target therapies for osteoarthritis based on 10 common Huoxue Huayu herbs and potential applications to other diseases

Zheng,Chun‑Song; Zhuang,Zhi‑Qiang; Xu,Xiao‑Jie; Ye,Jin‑Xia; Ye,Hong‑Zhi; Li,Xi‑Hai; Wu,Guang‑Wen; Xu,Hui‑Feng; Liu,Xian‑Xiang

doi:10.3892/mmr.2014.1914

In silico search for multi-target therapies for osteoarthritis based on 10 common Huoxue Huayu herbs and potential applications to other diseases

Authors:
- Chun‑Song Zheng
- Zhi‑Qiang Zhuang
- Xiao‑Jie Xu
- Jin‑Xia Ye
- Hong‑Zhi Ye
- Xi‑Hai Li
- Guang‑Wen Wu
- Hui‑Feng Xu
- Xian‑Xiang Liu
View Affiliations

Affiliations: Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fujian 350122, P.R. China, Affiliated Zhangzhou Hospital of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Fujian 363000, P.R. China
Published online on: January 22, 2014 https://doi.org/10.3892/mmr.2014.1914
Pages: 857-862

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Huoxue Huayu (HXHY) has been widely used in traditional Chinese medicine (TCM) as a key therapeutic principle for osteoarthritis (OA), and related herbs have been widely prescribed to treat OA in the clinic. The aims of the present study were to explore a multi-target therapy for OA using 10 common HXHY herbs and to investigate their potential applications for treatment of other diseases. A novel computational simulation approach that integrates chemical structure, ligand clusters, chemical space and drug‑likeness evaluations, as well as docking and network analysis, was used to investigate the properties and effects of the herbs. The compounds contained in the studied HXHY herbs were divided into 10 clusters. Comparison of the chemical properties of these compounds to those of other compounds described in the DrugBank database indicated that the properties of the former are more diverse than those of the latter and that most of the HXHY-derived compounds do not violate the ‘Lipinski's rule of five’. Docking analysis allowed for the identification of 39 potential bioactive compounds from HXHY herbs and 11 potential targets for these compounds. The identified targets were closely associated with 49 diseases, including neoplasms, musculoskeletal, nervous system and cardiovascular diseases. Ligand‑target (L‑T) and ligand‑target‑disease (L‑T‑D) networks were constructed in order to further elucidate the pharmacological effects of the herbs. Our findings suggest that a number of compounds from HXHY herbs are promising candidates for mult‑target therapeutic application in OA and may exert diverse pharmacological effects, affecting additional diseases besides OA.

View Figures

View References

1	Swoboda B: Epidemiological arthrosis research. Orthopade. 30:834–840. 2001.(In German).
2	Rubio-Terres C; Grupo del estudio VECTRA. An economic evaluation of chondroitin sulfate and non-steroidal anti-inflammatory drugs for the treatment of osteoarthritis. Data from the VECTRA study. Reumatol Clin. 6:187–195. 2010.(In Spanish).
3	Bitton R: The economic burden of osteoarthritis. Am J Manag Care. 15(Suppl 8): S230–S235. 2009.PubMed/NCBI
4	Guo ZR: Drug promiscuity. Yao Xue Xue Bao. 46:361–369. 2011.(In Chinese).
5	Frantz S: Drug discovery: playing dirty. Nature. 437:942–943. 2005. View Article : Google Scholar : PubMed/NCBI
6	Ernst E: Complementary or alternative therapies for osteoarthritis. Nat Clin Pract Rheumatol. 2:74–80. 2006. View Article : Google Scholar
7	Rezende MU, Gurgel HM, Vilaca PR Jr, Kuroba RK, Lopes AS, Phillipi RZ and Hernandez AJ: Diacerhein versus glucosamine in a rat model of osteoarthritis. Clinics (Sao Paulo). 61:461–466. 2006. View Article : Google Scholar : PubMed/NCBI
8	Choi JH, Choi JH, Kim DY, Yoon JH, Youn HY, Yi JB, Rhee HI, Ryu KH, Jung K, Han CK, et al: Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model. Osteoarthritis Cartilage. 10:471–478. 2002. View Article : Google Scholar
9	Wang P, Gu EP and Cao HY: Effect of Huoxue Huayu plaster on NO and MMP-13 in joint fluid of osseous arthritis of knee in the early and middle stage. Tianjin Zhong Yi Yao. 27:192–193. 2010.(In Chinese).
10	Wang P, Gu EP and Cao HY: Clinical efficacy observation for osseous arthritis of knee in the early and middle stage treated with Huoxue Huayu plaster. Jilin Zhong Yi Yao. 30:491–492. 2010.
11	Liu XX, Li XH and Zhou JT: Research on mechanism of Tougu Xiaotong Granule in preventing and treating knee osteoarthritis. Zhongguo Zhong Xi Yi Jie He Za Zhi. 27:50–54. 2007.(In Chinese).
12	Yu F, Li X, Cai L, Li H, Chen J, Wong X, Xu H, Zheng C, Liu X and Ye H: Achyranthes bidentata polysaccharides induce chondrocyte proliferation via the promotion of the G₁/S cell cycle transition. Mol Med Rep. 7:935–940. 2013.
13	Zhu HF, Wang WJ and Wang ZM: Recent advances of Drynaria fortunei. Zhongguo Gu Shang. 1:66–68. 2009.(In Chinese).
14	Qiao X, Hou T, Zhang W, Guo S and Xu X: A 3D structure database of components from Chinese traditional medicinal herbs. J Chem Inf Comput Sci. 42:481–489. 2002. View Article : Google Scholar : PubMed/NCBI
15	Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B and Hassanali M: DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36:D901–D906. 2008. View Article : Google Scholar : PubMed/NCBI
16	Dobson CM: Chemical space and biology. Nature. 432:824–828. 2004. View Article : Google Scholar : PubMed/NCBI
17	Huang Q, Qiao X and Xu X: Potential synergism and inhibitors to multiple target enzymes of Xuefu Zhuyu Decoction in cardiac disease therapeutics: a computational approach. Bioorg Med Chem Lett. 17:1779–1783. 2007. View Article : Google Scholar
18	Lipinski CA, Lombardo F, Dominy BW and Feeney PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 46:3–26. 2001. View Article : Google Scholar : PubMed/NCBI
19	Bonnet CS and Walsh DA: Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford). 44:7–16. 2005. View Article : Google Scholar
20	Loeser RF: Articular cartilage nuclear receptors: an emerging target for treatment of osteoarthritis. Osteoarthritis Cartilage. 17:829–831. 2009. View Article : Google Scholar : PubMed/NCBI
21	Tenor H, Hedbom E, Hauselmann HJ, Schudt C and Hatzelmann A: Phosphodiesterase isoenzyme families in human osteoarthritis chondrocytes - functional importance of phosphodiesterase 4. Br J Pharmacol. 135:609–618. 2002. View Article : Google Scholar
22	Montes M, Braud E, Miteva MA, Goddard ML, Mondesert O, Kolb S, Brun MP, Ducommun B, Garbay C and Villoutreix BO: Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors. J Chem Inf Model. 48:157–165. 2008. View Article : Google Scholar : PubMed/NCBI
23	Zhu F, Shi Z, Qin C, Tao L, Liu X, Xu F, Zhang L, Song Y, Liu XH, Zhang J, et al: Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 40:D1128–D1136. 2012.PubMed/NCBI
24	Smoot ME, Ono K, Ruscheinski J, Wang PL and Ideker T: Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
25	Assenov Y, Ramirez F, Schelhorn SE, Lengauer T and Albrecht M: Computing topological parameters of biological networks. Bioinformatics. 24:282–284. 2008. View Article : Google Scholar : PubMed/NCBI
26	Haringman JJ, Ludikhuize J and Tak PP: Chemokines in joint disease: the key to inflammation? Ann Rheum Dis. 63:1186–1194. 2004. View Article : Google Scholar : PubMed/NCBI
27	Wagner H: Multitarget therapy - the future of treatment for more than just functional dyspepsia. Phytomedicine. 13(Suppl 5): 122–129. 2006. View Article : Google Scholar : PubMed/NCBI
28	Espinoza-Fonseca LM: The benefits of the multi-target approach in drug design and discovery. Bioorg Med Chem. 14:896–897. 2006. View Article : Google Scholar : PubMed/NCBI
29	Jeong H, Mason SP, Barabasi AL and Oltvai ZN: Lethality and centrality in protein networks. Nature. 411:41–42. 2001. View Article : Google Scholar : PubMed/NCBI
30	Wang X, Zang B, Wu W, Tong J and Jin M: Protective effect of hydroxysafflor yellow A on endothelial cell injury induced by lipopolysaccharide. Zhongguo Zhong Yao Za Zhi. 36:1650–1653. 2011.(In Chinese).
31	Rosenbaum CC, O’Mathuna DP, Chavez M and Shields K: Antioxidants and antiinflammatory dietary supplements for osteoarthritis and rheumatoid arthritis. Altern Ther Health Med. 16:32–40. 2010.PubMed/NCBI
32	Luo P, Tan Z, Zhang Z, Li H and Mo Z: Inhibitory effects of salvianolic acid B on the high glucose-induced mesangial proliferation via NF-κB-dependent pathway. Biol Pharm Bull. 31:1381–1386. 2008.PubMed/NCBI
33	Li AZ: The therapeutic effect of retinal vein occlusion with Huoxue Huayu method in traditional Chinese medicine. Guiding J Trad Chin Med Pharm. 19:63–65. 2013.(In Chinese).
34	Zhang P, Wang H and Ou YL: The therapeutic experience of Huoxue Huayu method in diabetic nephropathy. J Pract Tradit Chin Med. 2:1302013.(In Chinese).
35	Gao CX: Clinical practice of Huoxue Huayu method in eye diseases treatment. Seek medical and ask the medicine. 10:622012.(In Chinese).
36	Liu H, Wang J, Zhou W, Wang Y and Yang L: Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice. J Ethnopharmacol. 146:773–793. 2013. View Article : Google Scholar : PubMed/NCBI
37	Tanabe H, Suzuki H, Nagatsu A, Mizukami H, Ogihara Y and Inoue M: Selective inhibition of vascular smooth muscle cell proliferation by coptisine isolated from Coptis rhizoma, one of the crude drugs composing Kampo medicines Unsei-in. Phytomedicine. 13:334–342. 2006. View Article : Google Scholar
38	Gong LL, Fang LH, Wang SB, Sun JL, Qin HL, Li XX, Wang SB and Du GH: Coptisine exert cardioprotective effect through anti-oxidative and inhibition of RhoA/Rho kinase pathway on isoproterenol-induced myocardial infarction in rats. Atherosclerosis. 222:50–58. 2012. View Article : Google Scholar